Trial Profile
A Study to Evaluate the Impact of Early Redosing of Natalizumab after Delivery on the Risk of Post-Partum Relapses in Women With Very Active Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Apr 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 12 Apr 2016 New trial record